Moreover, it is known that AKT, a serine/threonine kinase, plays an important role in anti-apoptotic signaling, targeting proteins such as BAD, caspase-9 and p53 [52,53], thus being implicated in several aggressive human cancers, including AML [54]. Here, MARK2 is linked to acute myeloid leukemia.